CNQ Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
CNQ is not a strong buy right now for a beginner long-term investor with $50,000-$100,000 to deploy. The stock has decent long-term quality and analyst support, but current earnings are down sharply year over year, hedge funds are selling aggressively, and the technical setup is only moderately constructive rather than a clean entry. Since the investor is impatient and does not want to wait for the best entry, I would still not call this a buy today; I would hold and wait for a clearer pullback or stronger momentum confirmation.
Current price is 45.18, slightly above the referenced option current price of 44.74, with the stock closed near support at S1 44.377 and above S2 43.282. The moving averages are bullish with SMA_5 > SMA_20 > SMA_200, which supports the longer-term trend. MACD histogram is slightly positive at 0.0114 but contracting, so momentum is not strengthening yet. RSI_6 at 35.102 is neutral-to-weak, suggesting the stock is not oversold enough to be an obvious buy. Overall, the trend is mildly bullish long term, but short-term momentum is mixed.
["Raymond James upgraded CNQ to Outperform and raised the target to C$67, citing improved visibility to debt reduction and materially higher shareholder returns.", "Scotiabank, Goldman Sachs, Morgan Stanley, Wells Fargo, and BMO have all raised price targets recently, showing improving Street expectations.", "Q1 adjusted EPS of C$1.17 beat expectations.", "Quarterly dividend of CAD 0.625 per share supports long-term income appeal.", "Gross margin improved year over year to 33.", "Options sentiment is bullish with low put-call ratios."]
["Q1 revenue fell 1.18% YoY and net income dropped 45.16% YoY, showing weaker fundamental growth.", "EPS dropped 45.30% YoY in the latest quarter.", "Hedge funds are selling heavily, with selling up 9618.75% over the last quarter.", "Technical momentum is not strong, with a contracting MACD histogram and RSI only around 35.", "Recent similar candlestick pattern data suggests limited near-term upside and slight weakness over the next week and month.", "No AI Stock Picker or SwingMax signal is active today."]
In Q1 2026, Canadian Natural reported revenue of 10.81 billion, down 1.18% year over year, net income of 1.348 billion, down 45.16% YoY, and EPS of 0.64, down 45.30% YoY. Gross margin improved to 33, up 1.48% YoY. News also notes adjusted earnings of C$1.17 per share beat analyst forecasts and cash flow generation was about C$4.4 billion, which is a positive sign for operating strength and dividend support. The latest quarter season is Q1 2026.
Recent analyst action is mostly positive: Raymond James upgraded CNQ to Outperform and raised its target to C$67, Wells Fargo raised its target to C$61, Morgan Stanley to C$66, Scotiabank to C$70, Goldman Sachs to C$49, and BMO to C$70. However, some firms remain cautious, including Wells Fargo at Equal Weight, Morgan Stanley at Equal Weight, Raymond James previously downgrading before reversing, and Veritas downgrading to Reduce. Wall Street pros appear broadly constructive on valuation and long-term energy cash flows, but there is still some split on near-term upside versus fair value.
